KRYS Krystal Biotech, Inc. CIK 0001711279 · last filing 2d ago · 3 insider transactions
$179.3K
2 buy transactions
$347.3K
1 sell transaction
Total flow
$526.5K
3 priced transactions
cross-source convergence Divergent 3/5 sources
Insider Funds Activist Sell Events 6 / 100 Recent disclosures · timeline Form 4 2d ago
EVP, General Counsel · sold $168.0K
Form 144 3d ago
Proposed sale of 1,000 sh ($347.3K) · discretionary
Price · KRYS Live chart by TradingView Most recent insider trade: Sold 1,000 sh @ $347.27 on Jun 25, 2026 view filing → Live chart via TradingView. Insider trade price and date are from the underlying SEC filing. Not financial advice.
KRYS insider flow· last 30 days net -$168.0K
max $347.3K/day May 27 — buy $0 · sell $0 · net +$0 May 28 — buy $0 · sell $0 · net +$0 May 29 — buy $0 · sell $0 · net +$0 May 30 — buy $0 · sell $0 · net +$0 May 31 — buy $0 · sell $0 · net +$0 Jun 1 — buy $0 · sell $0 · net +$0 Jun 2 — buy $0 · sell $0 · net +$0 Jun 3 — buy $0 · sell $0 · net +$0 Jun 4 — buy $0 · sell $0 · net +$0 Jun 5 — buy $0 · sell $0 · net +$0 Jun 6 — buy $0 · sell $0 · net +$0 Jun 7 — buy $0 · sell $0 · net +$0 Jun 8 — buy $0 · sell $0 · net +$0 Jun 9 — buy $0 · sell $0 · net +$0 Jun 10 — buy $0 · sell $0 · net +$0 Jun 11 — buy $0 · sell $0 · net +$0 Jun 12 — buy $0 · sell $0 · net +$0 Jun 13 — buy $0 · sell $0 · net +$0 Jun 14 — buy $0 · sell $0 · net +$0 Jun 15 — buy $0 · sell $0 · net +$0 Jun 16 — buy $0 · sell $0 · net +$0 Jun 17 — buy $0 · sell $0 · net +$0 Jun 18 — buy $0 · sell $0 · net +$0 Jun 19 — buy $0 · sell $0 · net +$0 Jun 20 — buy $0 · sell $0 · net +$0 Jun 21 — buy $0 · sell $0 · net +$0 Jun 22 — buy $0 · sell $0 · net +$0 Jun 23 — buy $0 · sell $0 · net +$0 Jun 24 — buy $0 · sell $0 · net +$0
Institutional holders · 13F Q1 2026 vs Q4 2025 · live SEC data 1 fund holds $1.02B reported value Net accumulating(1 adding · 0 reducing)
Fund Shares Value % of portfolio QoQ BlackRock Inc 3,940,456 $1.02B 0.1% Add
Proposed sales · Form 144 selling intent · live SEC data 1 notice $347.3K proposed to sell 0/1 under a 10b5-1 plan
Filed Filer Shares Est. value Approx. sale Source of shares Plan 3d ago Thomas John Charles
Officer
1,000 $347.3K Jun 25, 2026 Stock Option Exercise Discretionary
Recent insider transactions Filed Insider Transaction Shares Price Value Signal Flags 2d ago
Jun 25, 2026
Thomas John Charles EVP, General Counsel
1,000 $0.00 $0 Mild sell -19 Deriv
2d ago
Jun 25, 2026
Thomas John Charles EVP, General Counsel
1,000 $347.27 $347.3K Mild sell -19
2d ago
Jun 25, 2026
Thomas John Charles EVP, General Counsel
1,000 $179.25 $179.3K Mild sell -19
I Insider · Net insider selling F Institutional · 1 fund A Activist · — S Sell pressure · $347.3K planned E Events · — Institutions are accumulating (1 fund). Form 144 shows $347.3K of planned insider selling and insiders are net sellers.
Institutions accumulating+12 Planned insider selling (Form 144, $347.3K)-6
Convergence is a transparent heuristic sum of attributable disclosure factors — not a price target or recommendation. 8-K events are shown as context; Form 144 planned sales count against bullish conviction. Not financial advice.
Jun 25 — buy $179.3K · sell $347.3K · net -$168.0K May 27 Jun 25 
KRYSKrystal Biotech, Inc.